Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes
Publication year
2018Source
Haematologica, 103, 1, (2018), pp. 69-79ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Haematology
Laboratory Medicine
Tumorimmunology
Journal title
Haematologica
Volume
vol. 103
Issue
iss. 1
Page start
p. 69
Page end
p. 79
Subject
Radboudumc 11: Renal disorders RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 2: Cancer development and immune defence RIHS: Radboud Institute for Health Sciences; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences; Haematology - Radboud University Medical Center; Laboratory Medicine - Radboud University Medical Center; Radboud University Medical Center; Tumorimmunology - Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [242594]
- Electronic publications [129549]
- Faculty of Medical Sciences [92290]
- Open Access publications [104157]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.